Jennifer L. Guerriero, Alaba Sotayo, Holly E. Ponichtera, Jessica A.
Castrillon, Alexandra L. Pourzia, Sara Schad, Shawn F. Johnson, Ruben D.
Carrasco, Susan B. Lazo, Roderick T. Bronson, David H. Laidlaw, et al.
Abstract B35: Class IIa HDAC inhibition promotes an
antitumor macrophage phenotype that induces breast tumor regression and
inhibits metastasis.
American Association for Cancer Research, 2018.
(bibtex:
Guerriero-2018-CIH).